About 2022 MedCon
The premier medical device conference driving the speed of innovation.
The Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS) have come together to support sharing, collaboration, and learning across the global healthcare products community.
With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Heath’s legacy of delivering the FDA/Xavier MedCon Conference.
The AFDO/RAPS Healthcare Products Collaborative reflects the commitment of both organizations to continue the important work Xavier Health has done to advance the industry. This new partnership will also produce Xavier Health’s other industry events—including the PharmaLink Conference, Combination Products Summit, and AI Summit.
Prior MedCon Conferences have been credited with providing open, transparent interactions with stakeholders, and the AFDO/RAPS Healthcare Products Collaborative plans to support and enhance these efforts. During the 2022 conference, attendees will:
Experience paradigm-shifting dialogue leading to practical solutions that can be implement immediately
Learn proactive and predictive methods to protect products, businesses, and patients.
Gain cross-functional insights that foster critical alignment and collaboration across organization.
In 2022, this conference was co-sponsored by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services. The contents are those of the presenters and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.